Recursion Pharmaceuticals, Inc.RXRXNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank70
3Y CAGR-28.7%
Studio
Year-over-Year Change

Year-over-year total asset growth rate

3Y CAGR
-28.7%/yr
Quarterly compound
Percentile
P70
Within normal range
vs 3Y Ago
0.4x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q4 20255.33%
Q3 20257.46%
Q2 2025-0.22%
Q1 2025-9.90%
Q4 202499.39%
Q3 2024-6.36%
Q2 202439.08%
Q1 2024-14.66%
Q4 20233.63%
Q3 2023-5.38%
Q2 20236.27%
Q1 2023-10.54%
Q4 202214.68%
Q3 2022-9.07%
Q2 2022-8.42%
Q1 202220.31%
Q4 2021-7.33%
Q3 2021-5.72%
Q2 2021156.89%
Q1 2021-8.92%
Q4 20200.00%
Q3 20200.00%
Q2 20200.00%
Q1 20200.00%